FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...